Reference
Kok HT, et al. Challenges of monoclonal antibody therapy in multiple sclerosis: Case study. Multiple Sclerosis Journal 26: NP91-NP92 abstr. P-126, No. 9, Aug 2020. Available from: URL: http://doi.org/10.1177/1352458520925277 [abstract]
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1836, 35 (2021). https://doi.org/10.1007/s40278-021-87854-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-87854-0